CASC3 and neoplasm: Compared to administration as a free drug, delivery of BTZ with liposomes improved the therapeutic efficacy of BTZ alone or in combination with Y27632; this result is likely due to specific accumulation of the drugs in the tumor due to the EPR effect of liposomes13.